BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 18392331)

  • 21. Expression of biologically active kringle 5 domain of human plasminogen in Escherichia coli.
    Zhang HX; Fang L; Cheng J; Wei Z; Hua ZC
    Prep Biochem Biotechnol; 2005; 35(1):17-27. PubMed ID: 15704494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A deletion mutant of plasminogen kringle 5 inhibits retinal capillary endothelial cell proliferation].
    Ma JF; Yang ZH; Li CY; Cai WB; Song ZH; Guo Y; Guo LL; Li MY; Liu ZG; Gao GQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1245-8. PubMed ID: 14678880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene].
    Yang J; Wang YX; Guan XQ; Ma CG; Wang LS; Song HY
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):217-22. PubMed ID: 15966325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.
    Xin L; Xu R; Zhang Q; Li TP; Gan RB
    Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
    Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
    Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen.
    Chang JH; Javier JA; Chang GY; Oliveira HB; Azar DT
    FEBS Lett; 2005 Jul; 579(17):3601-6. PubMed ID: 15978592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of human thrombomodulin domain as a novel angiogenic factor.
    Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
    Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
    Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
    Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-x(L) subcellular distribution.
    Gu X; Yao Y; Cheng R; Zhang Y; Dai Z; Wan G; Yang Z; Cai W; Gao G; Yang X
    Apoptosis; 2011 Aug; 16(8):846-55. PubMed ID: 21656147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and characterization of Kringle 1-4.5 domains of human plasminogen].
    Zhou QW; Xie JL; Xin L; Xu R; Ye Q; Li ZP; Gan RB
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):138-42. PubMed ID: 12545220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
    Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
    Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.